IntraBio Inc.’s drug for neurogenerative disorder gets US regulator’s nod
IntraBio Inc, a biotechnology company focused on rare and neurogenerative diseases, got the US regulator’s nod for a drug to treat a certain.
Drugs
Health
Pharma